The most recent new treatment for Alzheimer’s disease was approved by European regulators in May 2002, with the US FDA following suit the next year.
from The Pharma Letter
As patients, physicians and pharma firms digest the latest research, presented at last week’s Alzheimer’s Association International Conference (AAIC), what can the pharmaceutical industry offer the estimated 50 million people living with this most burdensome of conditions?
Disclaimer: The viewpoint expressed in this article is the opinion of the author and is not necessarily the viewpoint of the owners or employees at Healthcare Staffing Innovations, LLC.
Researchers at the University of Pennsylvania are getting ready to test transplanting hepatitis C-infected hearts.
from AMA Wire
As many as 1,000 infected kidneys are thrown away each year in the United States, but new medications have made hepatitis C curable — and made it possible to consider using infected organs for transplants. That could cut down on the wait time not just for kidneys but also other organs, especially hearts.
Disclaimer: The viewpoint expressed in this article is the opinion of the author and is not necessarily the viewpoint of the owners or employees at Healthcare Staffing Innovations, LLC.
The possibility of curing sepsis with a common vitamin has put one of history’s greatest killers back in the spotlight.
from WebMD
The problem got a new look in recent months after Virginia doctors who used a cocktail of vitamin C, corticosteroids, and vitamin B1 said it helped fight off organ failure and death in patients with sepsis. Among 47 patients who received that mix, all but four survived, the doctors reported in a recent study.
Disclaimer: The viewpoint expressed in this article is the opinion of the author and is not necessarily the viewpoint of the owners or employees at Healthcare Staffing Innovations, LLC.
